NervGen Pharma Extends the Expiry Date of Certain Stock Options

Rhea-AI Summary

NervGen Pharma Corp. has extended the expiry date of certain stock options granted to a consultant, from three years to five years following the original grant dates. The exercise price and other terms of the options remain unchanged.

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2023) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced a two-year extension of the expiry date of certain stock options (the "Options") granted to a consultant of the Company on April 23, 2021 and July 16, 2021, such that the terms of the Options shall be extended from three (3) years to five (5) years following the original grant dates, respectively. All other terms of the Options, including the exercise price, remain the same.

About NervGen

NervGen is a clinical stage biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The Company's initial target indications are spinal cord injury, Alzheimer's disease, and multiple sclerosis. For more information, go to www.nervgen.com.

For further information, please contact:

Bill Adams, Chief Financial Officer
badams@nervgen.com

Huitt Tracey, Corporate Communications
htracey@nervgen.com
604.537.2094

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/168629

FAQ

What is the name of the company that made the announcement?

The company that made the announcement is NervGen Pharma Corp.

What is the purpose of NervGen Pharma Corp.?

NervGen Pharma Corp. is a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage.

What is the stock symbol of NervGen Pharma Corp. on the TSX Venture Exchange?

The stock symbol of NervGen Pharma Corp. on the TSX Venture Exchange is NGEN.

What is the stock symbol of NervGen Pharma Corp. on the OTCQX market?

The stock symbol of NervGen Pharma Corp. on the OTCQX market is NGENF.

What is the duration of the extension for the stock options?

The expiry date of the stock options has been extended from three years to five years following the original grant dates.

When were the stock options granted to the consultant?

The stock options were granted to the consultant on April 23, 2021, and July 16, 2021.

What remains unchanged in the terms of the options?

The exercise price and other terms of the options remain the same.